Conversely, we identified that tumours with low ratios enrich inflammatory/ECM-disrupting genes, such as IL6R, VCAM1, and MMP13, which collectively drive immune suppression and metastasis, in accordance with a poor prognosis and increased invasiveness. Here, IL6R is linked to neoplasm.